Prof Sarah Tabrizi talks about the ground-breaking Huntington’s drug set for global study

Prof Sarah Tabrizi talks about the ground-breaking Huntington’s drug set for global study

Publication date: May 13, 2019

Listen to UCL/UCLH researcher Sarah Tabrizi talk about how researchers are set to carry out a large-scale, global study of a ground-breaking Huntington’s disease drug which is the first in the world to lower the level of the harmful huntingtin protein which causes Huntington’s.

Follow us on twitter: @UCLHresearch

Visit our website: www.uclhospitals.brc.nihr.ac.uk

Concepts Keywords
Huntingtin Huntingtin
Huntington Huntington, Oregon
Nihr Huntingtons
Sarah Tabrizi
Huntington’s disease
Branches of biology
Scientists

Semantics

Type Source Name
gene UNIPROT LARGE1
gene UNIPROT SET
gene UNIPROT WDFY2

Similar

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *